Hypertensive emergency
Diagnosis
- End-organ damage 2/2 increased BP (generally >180/120, usually > 220/130)
- Brain - Encephelopathy, seizure, ICH, ischemic stroke
- Eyes - Retinal hemorrhage, exudate, papilledema
- CV - MI, CHF/LV failure/pulm edema, aortic dissection
- Renal - Acute failure, hematuria, proteinuria
- Ancillary Tests
- Chemistry - assess renal failure
- UA - Assess renal failure, glomerulo nephritis, preeclampsia
- Troponin
- CXR - Evidenceo failure, dissection
- ECG
Etiology
- Idiopathic
- Sympathomimetic drug use
- Preeclampsia
- Acute glomerulonephritis
Treatment
- Goal: Lower diastolic pressure to 105mmHg within 2-6 hours
- Maximum initial fall in BP should not exceed 25% of presenting value
- Be careful of lowering BP in pts with CVA!
| Drug | Dose | Mechanism | Pros | Cons | Notes |
| Nitroprusside |
0.25-8 ?g/kg/min (start at 0.25) |
Arterial and veno-dilator |
1. Very effective 2. Immediate onset/offset |
1. Cyanide Toxicity 2. Coronary steal? 3. Incr HR |
1. Avoid in liver/renal failure 2. Avoid with incr ICP 3. Avoid in pregnancy |
| Nitgroglycerin | 5-100 ?g/min | Veno>arteriodilation |
1. Rapid on/offset 2. Increases coronary flow |
Causes Tachycardia |
Drug of choice in pts w/ cardiac ischemia, LV dysfunction, and pulm edema |
| Labetalol |
20-80mg IV bolus q10min OR 0.5-2mg/min IV |
Beta>alpha blocker |
1. No change in HR, cerebral flow 2. Rapid onset |
Avoid in COPD, CHF heart block |
1. Consider in ACS 2. Consider in ischemic CVA |
| Esmolol |
250-500 ?g/kg/min; may repeat bolus after 5min or incr to 300 ?g/min |
Beta selective | 1. Rapid on/offset |
Avoid in COPD, CHF bradycardia |
Consider in ACS |
| Nicardipine | 5-15mg/h |
Decreases PVR |
Good for intracranial pathology | Slower onset/offset | Avoid in CHF, ACS |
| Hydralazine | 5-10mg IV bolus, max dose 20mg OR 0.5-1mg/min IV infusion | Arteriolar vasodilator | Rarely causes hypotension | Avoid in CAD | Primarily used in pregancy |
| Phentolamine |
5-10mg IV bolus q5-15min OR 0.2-5mg/min IV infusion |
Alpha blocker | Used for catecholamine-induced HTN | ||
| Enalapril | 1.25mg over 5min q6hr | Decreases HR, SV, systemic arterial pressure | Does not impair cerebral flow | Variable response |
1. Used in pts at risk for cerebral hypotension, CHF 2. Avoid in pregnancy |
Disease Specific
HTN Encephalopathy
Controlled redxn of BP over 1h; never < 110 diastolic
Labetolol, nicardipine, fenoldopam; nitroprusside of diastolic > 140
Stroke
10-15% reduction of MAP; diastolic not < 110
lower to 185/110 in ischemic stroke to meet t-PA criteria
Labetolol, nicardipine, nitroprusside as above
Acute Aortic Dissection
Rapid redxn of BP, systolic bp 100-120; HR 60-80 within 20mins
Prevent reflex tachycardia
Nitroprusside, fenoldopam, nicardipine with metoprolol or esmolol; labetolol alone
ACS and Pulmonary Edema
Nitroglycerin
Eslampsia/Pre-eclampsia
Labetolol, nicardipine or IV hydralazine
Magnesium
Cocaine and Amphetamine Toxicitiy
BDZs
Mixed alpha + B blockade: phentolamine or nitroprusside plus beta blocker
Pheochromocytoma
Phentolamine or nitroprusside plus beta blocker
ARF
Fenoldopam, nicardipine; nitroprusside risk cyanide toxicity (renal metabolism)
Source
Adapted from Bessen, Bresler (ACEP '09), UpT
Diagnosis
- End-organ damage 2/2 increased BP (generally >180/120, usually > 220/130)
- Brain - Encephelopathy, seizure, ICH, ischemic stroke
- Eyes - Retinal hemorrhage, exudate, papilledema
- CV - MI, CHF/LV failure/pulm edema, aortic dissection
- Renal - Acute failure, hematuria, proteinuria
- Ancillary Tests
- Chemistry - assess renal failure
- UA - Assess renal failure, glomerulo nephritis, preeclampsia
- Troponin
- CXR - Evidenceo failure, dissection
- ECG
Etiology
- Idiopathic
- Sympathomimetic drug use
- Preeclampsia
- Acute glomerulonephritis
Treatment
- Goal: Lower diastolic pressure to 105mmHg within 2-6 hours
- Maximum initial fall in BP should not exceed 25% of presenting value
- Be careful of lowering BP in pts with CVA!
Drug Dose Mechanism Pros Cons Notes
Nitroprusside 0.25-8µg/kg/min
(start at 0.25)
Arterial and veno-dilator 1. Very effective
2. Immediate onset/offset
1. Cyanide Toxicity
2. Coronary steal?
3. Incr HR
1. Avoid in liver/renal failure
2. Avoid with incr ICP
3. Avoid in pregnancy
Nitgroglycerin 5-100 µg/min Veno>arteriodilation 1. Rapid on/offset
2. Increases coronary flow
Causes Tachycardia Drug of choice in pts w/ cardiac ischemia,
LV dysfunction, and pulm edema
Labetalol 20-80mg IV bolus q10min OR
0.5-2mg/min IV
Beta>alpha blocker 1. No change in HR, cerebral flow
2. Rapid onset
Avoid in COPD, CHF
heart block
1. Consider in ACS
2. Consider in ischemic CVA
Esmolol 250-500 µg/kg/min;
may repeat bolus after
5min or incr to 300µg/min
Beta selective 1. Rapid on/offset Avoid in COPD, CHF
bradycardia
Consider in ACS
Nicardipine 5-15mg/h Decreases PVR Good for intracranial pathology Slower onset/offset Avoid in CHF, ACS
Hydralazine 5-10mg IV bolus, max dose 20mg OR 0.5-1mg/min IV infusion Arteriolar vasodilator Rarely causes hypotension Avoid in CAD Primarily used in pregancy
Phentolamine 5-10mg IV bolus q5-15min OR
0.2-5mg/min IV infusion
Alpha blocker Used for catecholamine-induced HTN Enalapril 1.25mg over 5min q6hr Decreases HR, SV, systemic arterial pressure Does not impair cerebral flow Variable response 1. Used in pts at risk for cerebral hypotension, CHF
2. Avoid in pregnancy
Disease Specific
HTN Encephalopathy
Controlled redxn of BP over 1h; never < 110 diastolic
Labetolol, nicardipine, fenoldopam; nitroprusside of diastolic > 140
Stroke
10-15% reduction of MAP; diastolic not < 110
lower to 185/110 in ischemic stroke to meet t-PA criteria
Labetolol, nicardipine, nitroprusside as above
Acute Aortic Dissection
Rapid redxn of BP, systolic bp 100-120; HR 60-80 within 20mins
Prevent reflex tachycardia
Nitroprusside, fenoldopam, nicardipine with metoprolol or esmolol; labetolol alone
ACS and Pulmonary Edema
Nitroglycerin
Eslampsia/Pre-eclampsia
Labetolol, nicardipine or IV hydralazine
Magnesium
Cocaine and Amphetamine Toxicitiy
BDZs
Mixed alpha + B blockade: phentolamine or nitroprusside plus beta blocker
Pheochromocytoma
Phentolamine or nitroprusside plus beta blocker
ARF
Fenoldopam, nicardipine; nitroprusside risk cyanide toxicity (renal metabolism)
Source
Adapted from Bessen, Bresler (ACEP '09), UpToDate
